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Cryopyrin (CIAS1, NLRP3) and ASC are compo-
nents of the inflammasome, a multiprotein com-
plex required for caspase-1 activation and cyto-
kine IL-1bproduction.CIAS1mutations underlie
autoinflammation characterized by excessive
IL-1b secretion. Disease-associated cryopyrin
also causes a program of necrosis-like cell
death in macrophages, the mechanistic details
of which are unknown. We find that patient
monocytes carrying disease-associated CIAS1
mutations exhibit excessive necrosis-like death
by a process dependent on ASC and cathepsin
B, resulting in spillage of the proinflammatory
mediator HMGB1. Shigella flexneri infection
also causes cryopyrin-dependent macrophage
necrosis with features similar to the death
caused by mutant CIAS1. This necrotic death
is independent of caspase-1 and IL-1b, and
thus independent of the inflammasome. Fur-
thermore, necrosis of primary macrophages
requires the presence of Shigella virulence
genes. While similar proteins mediate pathogen-
induced cell death in plants, this report identifies
cryopyrin as an important host regulator of
programmed pathogen-induced necrosis in
animals, a process we term pyronecrosis.
INTRODUCTION
The CATERPILLER family (Harton et al., 2002) (CLR, also
known as NLR) is comprised of proteins involved in theCell Host &regulation of innate immunity (Inohara and Nunez, 2003;
Martinon and Tschopp, 2005). Functionally similar to the
evolutionarily conserved Toll-like receptors (TLRs),
increasing evidence suggests that CLRs may serve as
intracellular molecules that sense pathogen-derived
products (Hoffmann and Reichhart, 2002; Poltorak et al.,
1998). Significant attention has been focused one CLR
family member, cryopyrin, which is encoded by the gene
CIAS1. CIAS1 is mutated in a trio of dominantly inherited
periodic fevers: FCAS (familial cold autoinflammatory
syndrome), MWS (Muckle-Wells syndrome), and CINCA/
NOMID (chronic infantile neurological cutaneous and
articular syndrome/neonatal onset multisystemic auto-
inflammatory disease), which are proposed to represent
a continuum of severity for a single condition, CIAS1-
associated periodic syndrome (CAPS) (Aksentijevich
et al., 2002; Feldmann et al., 2002; Hoffman et al.,
2001a, 2001b).
Recent investigations have highlighted an essential role
for IL-1b in the development of mutant-CIAS1-associated
periodic fevers. Mutant CIAS1/NLRP3 causes elevated
levels of spontaneous and induced IL-1b both in vitro
and in vivo. Indeed, FCAS, MWS, and CINCA/NOMID
have all been successfully treated with daily doses of the
IL-1b receptor antagonist Anakinra (Kineret) (Goldbach-
Mansky et al., 2006; Hawkins et al., 2004; Hoffman
et al., 2004). Cryopyrin participates in the regulation of
IL-1b through involvement in a multimolecular complex
called the inflammasome (Agostini et al., 2004). This com-
plex, which also includes ASC (Apoptotic Speck protein
containing a CARD) and TUCAN, promotes activation of
caspase-1/ICE. In turn, caspase-1 then cleaves pro-IL-
1b to produce mature IL-1b, which is released from the
cell. Mutations in cryopyrin result in the hyperactivation
of this pathway, causing excessive IL-1b production and
the severe episodes of inflammation.Microbe 2, 147–159, September 2007 ª2007 Elsevier Inc. 147
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Programmed Necrosis Caused by Cryopyrin and ASCThe functions of cryopyrin in the immune system are not
limited to autoinflammatory disorders. Several recent re-
ports have established cryopyrin as an important adaptor
capable of organizing the inflammasome to elicit IL-1b re-
lease in response to bacterial, viral, and other proinflam-
matory stimuli (Kanneganti et al., 2006a, 2006b; Mariatha-
san et al., 2006; Martinon et al., 2006; Sutterwala et al.,
2006). However, it is not yet known if the protein has addi-
tional biologic functions in the containment of pathogens.
Clues regarding an additional role for cryopyrin in re-
sponse to pathogen may lie within its makeup. Cryopyrin
consists of an amino-terminal pyrin domain, a central
NACHT (NAIP,CIITA,HET-E, TP1) domain, and seven car-
boxy terminal LRRs (leucine-rich repeats). This architec-
ture is conserved in plants, where similar proteins com-
prise a subfamily of disease-resistant (R) proteins called
NB-LRRs (Ausubel, 2005; Chisholm et al., 2006). The NB-
LRR proteins respond to microbial pathogen by eliciting
a hypersensitive death response in infected cells, thus
resulting in elimination of the pathogen (Greenberg et al.,
1994; Nimchuk et al., 2003). Similarly, one mammalian
host response to microbial pathogen is macrophage/
monocyte necrotic-like death, which can lead to pathogen
elimination, but also toexacerbated inflammation andsep-
sis (Kryskoet al., 2006). Theparticipationof cryopyrin in ini-
tiating necrosis has been hinted at previously, as cryo-
pyrin-deficient macrophages demonstrate reduced levels
of cell death in response to the Gram-positive Staphylo-
coccus bacteria (Mariathasan et al., 2006). However, the
molecular players that mediate such a process and the
mechanismof this formof cell deathhaveyetbeendefined.
We report here that cryopyrin and ASC are required for
a process of necrotic-like cell death. We furthermore ex-
pand the capabilities of cryopyrin by demonstrating that
it mediates both the IL-1b and cell death response to
aGram-negative bacterium, S. flexneri, resulting in cellular
necrosis and the exacerbation of inflammation. The obser-
vation that Shigella-induced cell death is independent of
caspase-1 and IL-1b indicates that this process occurs
independently of inflammasome formation. It further sug-
gests that disease-associated cryopyrin represents a
hyperactive form of the protein, while the function of the
normal counterpart is to induce cell death only upon
stimulation with bacteria or other pathogens.
RESULTS
Expression of Disease-Associated CIAS1 Mutants
Induces a Necrotic-like Cell Death
Mutations in CIAS1 are associated with the periodic fever
syndromes FCAS, MWS, and CINCA/NOMID. Adenoviral
constructs were transduced at a moi = 1 to promote effi-
cient exogenous expression of wild-type CIAS1 or CIAS1
containing mutations encoding the disease-associated
amino acid changes A439V or R260W (Figure S1A in the
Supplemental Data available with this article online). A
fourth construct encoding LacZ was designed as a nega-
tive control. Expression of the disease-associated mu-
tants dramatically decreased cell viability in the THP-1148 Cell Host & Microbe 2, 147–159, September 2007 ª2007 Emonocytic cell line in three separate assays: the XTT as-
say (Figure 1A), trypan blue (Figure S1B), and Viaprobe
(Figure S1C). Staurosporine was used to induce apoptosis
in all of these assays. To determine themode of cryopyrin-
induced cell death, we examined the activation of cas-
pase-3. During apoptosis, caspase-3 undergoes activat-
ing cleavage. In turn, caspase-3 cleaves PARP and other
downstream substrates. Neither caspase-3 nor PARP
were cleaved in cells expressing a disease-associated
mutant cryopyrin, though both were cleaved in stauro-
sporine-treated cells (Figure 1B). Further, pretreatment
of cells with the pan-caspase inhibitor (zVAD-fmk) failed
to abrogate cell death (Figure 1C). These results indicate
that mutant-cryopyrin-induced cell death does not require
or proceed via caspase activation. DNA fragmentation,
another hallmark of apoptosis, was not observed in
mutant-cryopyrin-expressing cells (Figure 1D), though the
positive control, staurosporine, induced DNA fragmenta-
tion in a caspase-dependent manner (Figure 1D and Fig-
ure S2A). Moreover, in contrast to apoptotic cells, mu-
tant-cryopyrin-expressing cells did not demonstrate an
increase in mitochondrial membrane permeability at two
time points (summarized in Figure 1E, and shown in detail
in Figure S2B). Finally, electron microscopy shows that
mutant-cryopyrin-expressing cells exhibit morphological
features consistent with necrosis. Cells expressingmutant
cryopyrin demonstrate several of these features: (1) deg-
radation of the plasmamembrane, (2) dysmorphic/swollen
mitochondria, and (3) lack of chromatin condensation
(Figure 1F, middle panel). Staurosporine caused a typical
apoptotic morphology (Figure 1F, right panel). Taken to-
gether, our results support previous data indicating that
disease-associated variants of cryopyrin induce cell death
consistent with necrosis (Fujisawa et al., 2006).
Disease-Associated Cryopyrin Mutants Induce
Enhanced IL-1b Release, but Cell Death
Is Independent of Caspase-1 and IL-1b Signaling
CIAS1-associated periodic fevers are characterized by
excessive IL-1b production. To explore the mechanism
by which disease-associated cryopyrin causes cell death,
we first determined if this process is dependent on cas-
pase-1 or IL-1b. In agreement with previous observations,
substantially more IL-1b was released from cells express-
ing mutant cryopyrin than cells expressing wild-type cryo-
pyrin (Figure 2A) (Agostini et al., 2004; Dowds et al., 2004).
IL-18 is also regulated by caspase-1, and levels of IL-18
are greatly induced by disease-associated cryopyrin (Fig-
ure 2B). Treatment with YVAD-CHO, a specific peptide in-
hibitor of caspase-1, abrogatedmutant-cryopyrin-induced
release of IL-1b and IL-18 (Figures 2A and 2B.). However,
while YVAD-CHO successfully blocked IL-1b and IL18,
mutant-cryopyrin-induced cell death was unaffected (Fig-
ure 2C). Kineret (Anakinra), an IL-1 receptor antagonist
(IL-1Ra) also failed to diminish mutant-cryopyrin-induced
cell death (Figure 2D). To assure that the concentration of
Kineret was adequate to block the biologic function of IL-
1b, we measured its effect on IL-1b-mediated induction
of IL-8 (Figure 2E). Even at a concentration a log lowerlsevier Inc.
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Programmed Necrosis Caused by Cryopyrin and ASCFigure 1. Disease-Associated Cryopyrin Causes Necrotic-like Cell Death
(A) Cell viability is diminished in THP-1 cells expressing disease-associated CIAS1 mutants. XTT reduction was measured 24 hr after adenoviral
transduction.
(B) MutantCIAS1-induced cell death does not cause caspase-3 or PARP cleavage. Immunoblots for caspase-3 or its substrate PARPwere performed
on lysates made from cells infected with the indicated adenoviral constructs or treated with staurosporine. Cleaved caspase-3 and PARP are ob-
served in staurosporine-treated cells but not in THP-1 cells expressing wild-type or disease-associated A439V CIAS1.
(C) Incubation with 100 mM pan-caspase (zVAD-fmk) inhibitor does not substantially block cell death.
(D) THP-1 cells expressing the R260W or A439V disease-associated mutant die without exhibiting DNA fragmentation. DNA content was measured
by PI staining followed by flow cytometry. The percentage of cells with sub-G1 content, indicating the DNA fragmentation characteristic of apoptosis,
is shown.
(E) Disease-associated cryopyrin expression does not promote the loss of mitochondrial membrane potential. THP-1 cells were treated as indicated.
Mitochondrial membrane potential was measured with the potential-sensitive dye TMRE. Data summarized here are shown in Figure S2B.
(F) Representative EM images of wild-type cryopyrin (left), A439V-transduced (middle), and staurosporine-treated (right) THP-1 cells. A439V-
transduced cells demonstrate necrotic features, including (1) degradation of the plasma membrane, (2) dysmorphic/swollen mitochondria, and (3)
the lack of chromatin condensation. Staurosporine-treated cells exhibit a typical apoptotic morphology.
All values are the mean of three independent experiments. Error bars indicate standard deviation of the mean.than that used in the cell viability assay (Figure 2D), the
induction of IL-8 by IL-1b was abolished by Kineret. To-
gether, these results demonstrate that mutant-cryopyrin-
induced cell death occurs independently of caspase-1 ac-
tivity and IL-1b-mediatedsignaling.Aspreviously reported,
inhibition of cathepsin B with 50 mM Ca-074-Me substan-
tially blockedcell death causedbydisease-associatedcry-
opyrin but had no effect on staurosporine-induced death
(Fujisawa et al., 2006). Of note, Figure 1C shows that theCell Host & Mpan-caspase inhibitor caused a slight reversal of disease
variant cryopyrin-mediated cell death. This slight improve-
ment in viability may be attributed to cross inhibition of
cathepsin B by the zVAD peptide (Schotte et al., 1999).
Disease-Associated Mutant-Cryopyrin-Induced
Cell Death Is ASC Dependent
To further explore the mechanism by which disease-
associated CIAS1 causes cell death, the role of ASCicrobe 2, 147–159, September 2007 ª2007 Elsevier Inc. 149
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Programmed Necrosis Caused by Cryopyrin and ASCFigure 2. Disease-Associated CIAS1 In-
duces IL-1b Release, but Cell Death Is
IL-1b Independent
(A) IL-1b is released from THP-1 cells infected
with two mutant forms of CIAS1 as measured
by ELISA. IL-1b release is abrogated with
100 mM YVAD.
(B) IL-18 is released from THP-1 cells infected
with two mutant forms of CIAS1 as measured
by ELISA. IL-18 release is abrogated with
100 mM YVAD.
(C) Cell death induced by CIAS1mutants is not
inhibited by 100 mM YVAD. Viability was mea-
sured by XTT reduction 24 hr posttransduction.
(D) Kineret, the IL-1 receptor antagonist, does
not prevent cryopyrin-induced cell death.
THP-1 cells were infected with the indicated
adenovirus for 24 hr in the presence or ab-
sence of Kineret. NT, not treated with Kineret.
(E) IL-8 induction in THP-1 cells by recombi-
nant IL-1b is inhibited by Kineret. IL-1b induced
a significant level of IL-8 production; this bio-
logic effect of IL-1b was completely abrogated
by Kineret.
(F) Cell death induced by cryopyrin mutants is
blocked by a cathepsin B inhibitor, Ca-074-
Me. THP-1 cells were infected with the indi-
cated adenovirus for 24 hr in the presence or
absence of Ca-074-Me. Viability was mea-
sured by XTT reduction after 24 hr.
All values are the mean of three independent
experiments. Error bars indicate standard de-
viation of the mean.was examined. Short hairpin RNA molecules (shRNAs)
were designed to promote the degradation of ASC
mRNA (shASC). A control shRNA with a mutated target
ASC sequence was also prepared (shCntrl). These
shRNAs were incorporated into retrovirus and stably
transduced into THP-1 cells, resulting in stable reduction
of both ASC protein and mRNA (Figures 3A and 3B). A
second ASC shRNA generated the same results (data
not shown). Consistent with a role for ASC in the inflamma-
some, shASC diminished spontaneous production of IL-
1b induced by wild-type and mutant cryopyrin (Figure 3C).
More importantly, shASC reverted cell death induced by
the A439V disease-associated cryopyrin mutant
(Figure 3D). These results demonstrate that ASC is re-
quired for mutant-cryopyrin-induced cell death as well
as IL-1b production in monocytic/macrophage cell types.
Disease-Associated Cryopyrin Mutants Induce
HMGB1 Release
HMGB1 is emerging as an important therapeutic target for
sepsis, cancer, and other conditions. Normally maintained
as a nuclear factor within the healthy cell, HMGB1 takes on
the role of a strong proinflammatory factor when released
from cells undergoing necrosis (Scaffidi et al., 2002). This
prompted us to examine the release of HMGB1 in the
presence of disease-associated cryopyrin. As measured
by western analysis, HMGB1 release from cells trans-
duced with the wild-type CIAS1-adenovirus is barely150 Cell Host & Microbe 2, 147–159, September 2007 ª2007 Eldetectable, but a high level is released by cells expressing
either of two disease-associated forms of CIAS1 (Fig-
ure 4A). Though ASC is essential for HMGB1 release (Fig-
ure 4B), caspase-1 activity is not (Figure 4C). HMGB1
release following the induction of apoptosis with stauro-
sporine is not observed at the 6 hr time point but is only ob-
served 24 hr posttreatment. This is likely the consequence
of secondary necrosis caused by longer treatment time
(Figure S2C). Collectively, the results presented in Figures
3 and 4 suggest thatmutant cryopyrin causes necrotic-like
cell death and subsequent HMGB1 release in an ASC-
dependent but caspase-1-independent fashion.
LPS Induces Death of FCAS Patient Cells
We next sought to determine the effects of CIAS1 muta-
tion on cell viability in peripheral blood mononuclear cells
(PBMCs) from FCAS patients with confirmedCIAS1muta-
tions. Samples were obtained from patients with CIAS1
mutations who have not undergone anti-inflammatory
treatment. The endotoxin lipopolysaccharide (LPS) has
been used by others to induce monocytic cell death (Kar-
ahashi and Amano, 1998). LPS is also known to induce
CIAS1 mRNA and protein expression, both of which are
very low in resting mononuclear cells (O’Connor et al.,
2003). LPS challenge resulted in a dose-dependent de-
crease in cell viability in patient PBMCs but not healthy
controls, supporting the conclusions made from exoge-
nous expression of disease-associated cryopyrinsevier Inc.
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Programmed Necrosis Caused by Cryopyrin and ASCFigure 3. Mutant-CIAS1-Induced THP-1
Cell Death Is ASC Dependent
(A and B) Expression of ASC is markedly de-
creased in cells stably transduced with
shRNA designed to promote the degradation of
ASC mRNA (shASC). Immunoblot analysis
and real-time PCR of the indicated stable cell
lines verify a decrease of ASC protein (A) and
mRNA (B).
(C) IL-1b release following infection with
CIAS1-containing adenovirus is abrogated in
cells with shASC. IL-1b was determined by
ELISA. Values < 10 pg/ml are considered not
detectable (‘‘N/D’’).
(D) Mutant CIAS1-induced cell death is abro-
gated in cells with decreased expression of
ASC caused by shASC. XTT reduction was
measured 24 hr after adenoviral infection.
All values are the mean of three independent
experiments. Error bars indicate standard de-
viation of the mean.(Figure 5A). As disease-associated cryopyrin variants are
generally accepted as gain-of-function mutants, proper-
ties observed with disease-associated cryopyrin are ex-
pected to be observed with wild-type cryopyrin, either at
a reduced level or under stimulated conditions. While ad-
enovirus with disease-associated CIAS1 caused substan-
tial cell death at moi = 1, transduction of adenovirus con-
taining wild-type cryopyrin into THP-1 cells also resulted
in cell death when a higher moi was used (Figure 5B).
These findings prompted us to determine whether wild-
type cryopyrin plays a role in cell necrosis associated
with bacterial pathogenesis.
Shigella flexneri-Induced Cell Death Requires
Cryopyrin and ASC, but Not Caspase-1
Necrosis of monocytes and macrophages is a docu-
mented response to pathogenic bacteria, although
proteins that control this process are not well defined (Gol-
stein and Kroemer, 2007; Zong and Thompson, 2006).
Significant evidence indicates that Shigella causes a ne-
crotic-like cell death, although apoptosis has also been re-
ported (Koterski et al., 2005; Nonaka et al., 2003; Suzuki
et al., 2005; Zychlinsky and Sansonetti, 1997). This ledCell Host &us to examine the potential of wild-type cryopyrin to medi-
ate necrosis in response to Shigella flexneri. Stable reduc-
tion of cryopyrin protein in THP-1 cells was achieved utiliz-
ing retroviral-transduced shRNAs specific for CIAS1,
which caused a near-ablation of targeted gene expression
(Figure 6A). The induction of IL-1b by S. flexneriwas nearly
abolished in cryopyrin-deficient cells as measured by
ELISA, providing a biologic assay to assure that the
CIAS1 shRNA caused the intended biologic effect
(Figure 6B). More importantly, S. flexneri-induced death
was substantially abrogated in shCIAS1 cells (Figure 6C).
The presence of shCIAS1 did not affect staurosporine-
induced cell death, indicating specificity of cryopyrin for
S. flexneri-induced death. To confirm that cryopryin-
mediated cell death requires ASC, we tested the ability
of Shigella to elicit cell death and IL-1b in ASC-deficient
THP1 cells. As expected, both cell death and IL-1b release
were substantially abrogated in the shASC cells (Figures
6D and 6E).
To examine the physiologic importance of these results,
we utilized macrophages isolated from wild-type and
CIAS1 gene-ablated mice. In wild-type bone marrow-
derived macrophages, Shigella caused a 2.5- to 3-foldFigure 4. HMGB1 Is Released from THP-
1 Cells Following Expression of Disease-
Associated CIAS1 Mutants
(A) Two disease-associated CIAS1mutants in-
duce substantially more HMGB1 release than
the wild-type gene.
(B) HMGB1 release is abrogated in cells with
shASC, which reduced ASC expression.
(C) Inhibition of caspase-1 with YVAD-CHO
does not substantially affect HMGB1 release.
Nitrocellulose membranes stained with amido
black are provided as loading controls.Microbe 2, 147–159, September 2007 ª2007 Elsevier Inc. 151
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Programmed Necrosis Caused by Cryopyrin and ASCincrease in cell death compared to uninfected macro-
phages. However, in CIAS1/ macrophages, Shigella
failed to initiate cell death above the level of uninfected
cells (Figure 6F). Moreover, the level of IL-1b secretion
was reduced approximately 15-fold in peritoneal macro-
phages from CIAS1/mice (Figure 6G). The requirement
of CIAS1 for both cell death and IL-1b release in response
to S. flexneri establishes wild-type cryopyrin as a critical
host adaptor capable of responding to a Gram-negative
bacterial pathogen. In contrast, bone marrow-derived
macrophages isolated frommice lacking caspase-1 dem-
onstrated no differential cell death response to S. flexneri
(Figure 6H), though caspase-1 remained essential for
IL-1b activation (Figure 6I). These results indicate that
cryopyrin and ASC, but not caspase-1, are required for
S. flexneri-induced macrophage necrosis.
Cryopyrin-dependent cell death is not observed in cells
infected with another intracellular bacteria, Salmonella
typhi, thus indicating that the role of cryopyrin cannot be
generalized to all intracellular bacteria (Figure S3) (Maria-
thasan et al., 2006). To assess if cryopyrin-induced cell
death is caused by virulence factors expressed by S. flex-
neri, we compared avirulent, plasmid-cured S. flexneri
(BS103) and the virulent parental strain (2457T). The former
lacks a 230 kb virulence plasmid that encodes the invasion
plasmid antigens IpaB, IpaC, and IpaD. These antigens are
essential forS. flexneri virulence and entrance into the host
cell (Menard et al., 1993). Immunoblot analysiswas used to
confirm the plasmid-cured Shigella strain lacks the IpaB
Figure 5. Cell Death in Cells Isolated from FCAS Patients and
in Cells Expressing Wild-Type CIAS1
(A) Cell viability is decreased in PBMCs from FCAS patients in re-
sponse to LPS. XTT reduction was used to assay cell viability and
was measured 72 hr after stimulation. *p < 0.05, **p < 0.01 when com-
pared to controls.
(B) Cell viability is diminished in THP-1 cells expressing wild-type
CIAS1 at highermultiplicities of infection. XTT reductionwasmeasured
48 hr after adenoviral infection.
All values are the mean of three independent experiments. Error bars
indicate standard deviation of the mean.152 Cell Host & Microbe 2, 147–159, September 2007 ª2007 Elprotein, while this protein is detected in the parental strain
(Figure 6J, left panel, inset). Cell death was assayed at two
(2 and 4 hr) different time points. At both time points, viru-
lent Shigella (2457T) caused cell death, and this process
was reduced in macrophages lacking the CIAS1 gene
(Figure 6J, right and left panels). As expected, when mac-
rophages were infected with the plasmid-cured BS103
strain, cell death is reduced by >80%. This residual level
of cell death was not affected by the absence of CIAS1.
These results indicate that virulence factors expressed
by S. flexneri cause CIAS1-dependent cell death.
Cryopyrin Mediates Shigella-Induced
Necrotic-like Cell Death with Properties Similar
to Mutant-Cryopyrin-Induced Death
Having established that cryopyrin was essential for
Shigella-mediated cell death, we sought to determine
the nature of cell death and whether it was consistent
with the necrotic-like death induced by mutant cryopyrin.
Infection of shCTRL THP-1 cells with S. flexneri for 6 hr re-
sulted in cell death with features morphologically consis-
tent with necrosis (Figure 7A, compare 7Ai and 7Aii). To
verify that the necrotic cells contain bacteria, we per-
formed electron microscopy at an earlier time point (2 hr
after infection) when the cell morphology is less frag-
mented. Cells with a negative control shRNA that are in-
fected with bacteria demonstrate the initial loss of cyto-
plasm, indicating necrosis (Figure 7Aiii). In contrast,
cellular morphology consistent with cell death was not ob-
served in shCIAS1 cells, despite the presence of several
intracellular Shigella bacteria (Figure 7Aiv). Next, we ex-
amined biochemical properties of cryopyrin-initiated IL-
1b and cell death response to Shigella. In contrast to the
apoptotic control staurosporine, Shigella-induced cell
death did not result in the cleavage of PARP after 6 hr
(Figure 7B). Earlier reports have suggested that S. flexneri
induces apoptosis in macrophages at early time points,
while necrosis is observed at later points (Zychlinsky
et al., 1992; Koterski et al., 2005). We observed that treat-
ment with the pan-caspase inhibitor zVAD slightly dimin-
ished cell death after 2 hr of infection, but not after 6 hr
of infection. The caspase-1-specific inhibitor YVAD had
no effect. Attempts to inhibit cell death and IL-1b release
with glycine pretreatment, previously shown to reduce
Shigella-induced apoptosis, were also ineffective
(Figure S4) (Edgeworth et al., 2002). However, the cathep-
sin B inhibitor Ca-074-Me substantially blocked cell death,
further validating that mutant cryopyrin and Shigella-
induced necrosis occurred via the same pathway
(Figure 7C). Although the caspase-1 inhibitor YVAD failed
to block cell death, it substantially abrogated both IL-1b
and IL-18 in response to Shigella in shCTRL cells, indicat-
ing that cell death is predominantly caspase-1, IL-1b, and
IL-18 independent (Figures 7D and 7E). As expected,
shCIAS1 nearly abolished both IL-1b and IL-18. Finally,
Shigella-mediated cell death was associated with the re-
lease of HMGB1 (Figure 7F). In contrast, treatment with
apoptosis-inducing staurosporine for 2 and 6 hr did not
cause HMGB1 release.sevier Inc.
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Programmed Necrosis Caused by Cryopyrin and ASCFigure 6. Shigella flexneri-Induced Cell Death and IL-1b Require CIAS1 and ASC but Not Caspase-1
(A) Cryopyrin protein expression is decreased in THP-1 cells transduced with cryopyrin-specific shRNA (shCIAS1).
(B) S. flexneri-induced IL-1b release is diminished in CIAS1-deficient THP1 cells.
(C) THP-1 cells with shCIAS1 resist S. flexneri-induced death but not staurosporine-induced death.
(D and E) ASC is required for S. flexneri-induced cell death (D) and IL-1b release (E) in THP-1 cells.
(F) CIAS1/ bone marrow-derived macrophages exhibit decreased levels of cell death in response to S. flexneri.
(G) S. flexneri-induced IL-1b release from thioglycolate-elicited peritoneal macrophages is reduced in CIAS1/ macrophages.
(H) S. flexneri does not require Caspase-1 to initiate cell death.
(I) S. flexneri requires caspase-1 to induce IL-1b production in bone marrow-derived macrophages.
(J) Cryopyrin initiates cell death in response to virulent Shigella. Bone marrow-derived macrophages were infected with either 2457T (virulent) or
BS103 (avirulent) S. flexneri at a moi of 50 for 2 or 4 hr. Absence of virulence plasmid in BS103 was verified by ipaB immunoblot (inset). In all cases,
cell death was measured by 7-aad uptake or LDH release and IL-1b determined by ELISA.
All values are the mean of three independent experiments. Error bars indicate standard deviation of the mean.Thus, S. flexneri-induced death shared multiple charac-
teristics associated with the necrotic-like cell death ob-
served with disease-associated cryopyrin, suggestingCell Host &that this process is mediated by cryopyrin and ASC and
proceeds through cathepsin B independent of either cas-
pase-1 or IL-1b, resulting in HMGB1 release.Microbe 2, 147–159, September 2007 ª2007 Elsevier Inc. 153
Cell Host & Microbe
Programmed Necrosis Caused by Cryopyrin and ASCFigure 7. Shigella flexneri Induces Cryopyrin-Dependent Necrosis
(A) Infection with S. flexneri for 6 hr induced cell death that is morphologically consistent with necrosis (see Ai and Aii). To detect intracellular bacteria,
a shorter infection time (2 hr) was used so that the cells are just entering the initial phase of cell death. Cells with shCTRL, but not shCIAS1, exhibited
a lost of cytoplasmic content as determined by EM imaging. Insets show the presence of bacteria (opaque round or oblong structures).
(B) PARP is not cleaved following S. flexneri infection.
(C) Cathepsin B inhibitor (50 mM) (Ca-074-Me) substantially abrogates S. flexneri cell death. In contrast, 100 mMpan-caspase (zVAD-fmk) and 100 mM
caspase-1 specific (YVAD-CHO) inhibitors fail to block S. flexneri-induced cell death in shCTRL and shCIAS1 cells at 6 hr.
(D and E) S. flexneri-induced IL-1b (D) and IL-18 (E) release is reduced in shCIAS1 THP-1 cells and in cells treated with 100 mM YVAD-CHO.
(F) S. flexneri-induced HMGB1 release is abrogated by shCIAS1, and thus is cryopyrin dependent. In all cases, cell death was measured by 7-aad
uptake. IL-18 and IL-1b release were determined by ELISA.
All values are the mean of three independent experiments. Error bars indicate standard deviation of the mean.DISCUSSION
We report a necrotic-like cell death caused by disease-
associated mutants of CIAS1, which is dependent on
ASC but not on caspase-1 or IL-1b. This process results
in release of the proinflammatory mediator HMGB1, which154 Cell Host & Microbe 2, 147–159, September 2007 ª2007 Ellikely propagates the inflammatory response. Additionally,
we show that ASC and native, wild-type cryopyrin are re-
quired for S. flexneri-induced cell death, which proceeds
in a manner identical to that induced by disease-associ-
ated cryopyrin. These results implicate cryopyrin as a cru-
cial regulator of pathogen-induced necrotic-like death,sevier Inc.
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ogenesis of amyriad of infectious diseases, which we pro-
pose to call pyronecrosis.
From the perspective of cryopyrin-associated periodic
fever, these results and the accumulated data in the liter-
ature suggest that cryopyrin mutants directly regulate dis-
ease progression through at least two distinct signaling
pathways. It is known that cryopyrin participates in the ac-
tivation of caspase-1, the maturation of IL-1b, and subse-
quent hyperactivation of the inflammatory process via an
ASC-dependent process (Agostini et al., 2004). Previous
reports have indicated that disease-associated mutants
demonstrate a gain-of-function phenotype with respect
to these properties leading to enhanced IL-1b release
(Dowds et al., 2004). We report a second gain-of-function,
the induction of necrotic-like cell death. The manner of
death is particularly important. While it is generally be-
lieved that apoptotic cells die an orderly death with mini-
mal impact on inflammation, necrosis involves the spilling
of cellular contents into the environment, intensifying local
inflammation and damaging neighboring cells (Krysko
et al., 2006). It is important to keep in mind that the IL-1 re-
ceptor antagonist Anakinra has been successfully used to
treat patients suffering from CAPS, indicating that exces-
sive IL-1b production underlies disease. This would seem
to suggest that the inflammasome function of cryopyrin is
solely responsible for periodic fever in these patients.
However, given that necrosis allows for the release of
proinflammatory factors such as HMGB1, which in turn
promote further release of IL-1b, it is likely that cryo-
pyrin-mediated cell death also contributes to disease
state in patients.
Both disease-associated cryopyrin expression and
S. flexneri infection triggered the release of HMGB1,
a chromatin-associated protein released by necrotic cells.
Once HMGB1 is released, it acts as a potent danger indi-
cator, inducing several proinflammatory cytokines by sig-
naling through the RAGE, TLR2, and TLR4 receptors to
elicit a severe inflammatory response (Andersson et al.,
2000; Hori et al., 1995; Park et al., 2004). Serum HMGB1
is increased both during endotoxin exposure in mice and
in septic patients who succumbed to infection (Wang
et al., 1999). HMGB1 neutralization has been shown to
significantly reduce inflammation and improve survival in
animal models of established sepsis (Yang et al., 2004).
The release of HMGB1 elicited by bacterial-induced cell
death further supports the use of HMGB1 antagonists to
reduce inflammation during sepsis.
The results shown here demonstrate a requirement for
ASC in cryopyrin-induced cell death. ASC was initially
identified as a cytosolic protein aggregated into specks
in myeloid cells undergoing apoptosis and has since
been implicated in several cell death pathways in nonmye-
loid cells (Masumoto et al., 1999). Functionally ASC is a bi-
partite adaptor protein comprised of N-terminal pyrin do-
main (PD) and C-terminal CARD. It is proposed that these
domains each engage in homotypic interactions, thereby
linking the PD of cryopyrin to the CARD region of cas-
pases. Constitutive interactions between several trans-Cell Host & Mfected disease-associated cryopyrin mutants and ASC
have been reported when overexpressed in a HEK293T
cells (Dowds et al., 2004). Overexpressed ASC has also
been shown to interact with caspases-8 and-9, and sev-
eral studies have implicated ASC in the progression of
apoptosis. The concurrent overexpression of a related
protein, Ipaf, with ASC in HEK293T cells results in cas-
pase-8-dependent apoptosis, while overexpression of
ASC alone induces caspase-9-mediated cell death in
HEK293 cells (Masumoto et al., 2003; McConnell and Ver-
tino, 2000). These observations suggest the involvement
of apoptotic caspases in ASC-induced cell death in non-
monocytic cells (Dowds et al., 2004; Masumoto et al.,
2003; Wang et al., 2004). However, coimmunoprecipita-
tion experiments in monocytic THP-1 cells indicate that
ASC/caspase interaction is limited to caspase-1, suggest-
ing that ASC is not involved in the initiation of apoptotic
caspases in these cells (Stehlik et al., 2003). Our results
in a monocytic cell type demonstrate that ASC is impor-
tant in a necrotic-like cell death pathway that is caspase
independent.
The results here delineate an endogenous program of
necrosis initiated by cryopyrin and ASC. This pathway
proceeds through cathepsin B, yet occurs independent
of caspase-1, IL-1b, and the inflammasome. Recently,
ASC has also been implicated in the initiation of another
rapid form of inflammatory cell death called pyroptosis.
In contrast to the necrosis initiated by cryopyrin and
ASC, pyroptosis requires caspase-1 activation by ASC
following the dimerization of ASC into speck-like pyropto-
somes (Fernandes-Alnemri et al., 2007). Pyroptosomes
per se do not contain detectable cryopyrin; however, the
role of cryopyrin in the formation of this structure was
not tested. This form of cell death has features of both ap-
optosis and oncosis. Unlike the cryopyrin/ASC necrosis
pathway described here, pyroptosis can be blocked by
exogenous caspase inhibitors; however, the requirement
for cathepsin B has not been investigated (Fernandes-
Alnemri et al., 2007). The involvement of ASC in the induc-
tion of both pyronecrosis and pyroptosis establish ASC as
a key component in the host defense arsenal to invading
pathogens.
Several recent reports establish cryopyrin as a pivotal
regulator of IL-1 and IL-18 release to both bacterial and
viral challenges. Utilizing macrophages isolated from
CIAS1/ mice, components of the immune response to
Gram-positive bacteria such as Staphylococcus aureus
and Listeria monocytogenes, as well as Sendai and influ-
enza viruses, have been shown to require cryopyrin (Kan-
neganti et al., 2006a; Mariathasan et al., 2006). However,
infection with Gram-negative Salmonella typhimurium or
Francisella tularensis elicits caspase-1 activation and IL-
1b release in a cryopyrin-independent fashion (Mariatha-
san et al., 2005; Sutterwala et al., 2006). Macrophage
cell death induced by Salmonella and Francisella are sim-
ilarly unaffected by CIAS1 deficiency (Mariathasan et al.,
2005). Alternate proteins mediate the response to these
pathogens. Ipaf, which participates in its own inflamma-
some, is responsible for initiating inflammation inicrobe 2, 147–159, September 2007 ª2007 Elsevier Inc. 155
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2004). It has been suggested that cryopyrin does not me-
diate the recognition of Gram-negative bacteria. However,
our results indicate that cryopyrin mediates both IL-1b
release and cell death in response to the Gram-negative
bacteria S. flexneri in THP-1 cells and mouse macro-
phages (Figure 7). Thus, cryopyrin mediates IL-1b pro-
cessing and secretion in response to specific Gram-
positive and -negative bacteria.
Despite substantial progress made in understanding
pathogen-induced host cell death, the mechanisms gov-
erning Shigella-induced host cell death have not been
conclusively delineated (Haimovich and Venkatesan,
2006). This study illuminates a necrotic host cell-death
pathway detonated by Shigella requiring both cryopyrin
and ASC. While the strain M90T (Serogroup 5) has been
reported to induce both necrosis and caspase-1-depen-
dent apoptosis (Francois et al., 2000; Raqib et al., 2002;
Zychlinsky et al., 1992), many others have observed cas-
pase-1-independent necrosis initiated by strains 2457T
(Serogroup 2A), YSH6000 (Serotype 2A), and now 12022
(Serogroup 2B) (Fernandez-Prada et al., 1997, 2000; Ko-
terski et al., 2005; Nonaka et al., 2003). These differences
have been attributed to differences in species and in-
fected cell types, Shigella strains, duration and multiplicity
of infection, and conclusions regarding the nature of cell
death drawn from incomplete methodology (Nonaka
et al., 2003). The results presented here verify and define
cryopyrin and ASC as key components of a caspase-1-
independent mechanism by which Shigella induces ne-
crosis and should do much to advance the understanding
of Shigella pathogenesis.
Further resolved is the putative involvement of caspase-
1 in mediating Shigella-induced cell death. Previous re-
ports have suggested that the virulence factor IpaB is se-
creted by Shigella via a type III secretion system upon
contact with host cells and subsequently binds directly
to caspase-1 to induce cell death (Blocker et al., 1999;
Chen et al., 1996; Menard et al., 1994). Our results clearly
demonstrate a caspase-1-independent pathway, as both
caspase-1-specific inhibitors and macrophages lacking
caspase-1 were equally susceptible to Shigella-induced
cell death as wild-type controls, a result consistent with
other reports (Suzuki et al., 2005). It should be noted
that Suzuki et al. observed an early apoptotic event requir-
ing caspase-1, and IpaB preceded a later necrotic event
that occurs independent of caspase-1 or IpaB, and thus
both outcomes are possible. While we show here that cry-
opyrin and ASC are required for Shigella-initiated necro-
sis, the activation of NF-lB and JNK in epithelial cell line
following Shigella infection has been reported to require
the overexpression of NOD1/CARD4 (Girardin et al.,
2001). Although verification of this finding using primary
epithelial cells from mice lacking NOD1/CARD4 has not
been performed to confirm the physiologic relevance of
this data, taken together, these data suggest that several
CLR proteins might mediate different aspects of the
immune response to Shigella in a cell-type specific
fashion.156 Cell Host & Microbe 2, 147–159, September 2007 ª2007 EIn summary, we report that disease-associated cryo-
pyrin mediates a form of necrotic-like cell death that is
replicated when normal monocytes encounter the bacte-
rial pathogen S. flexneri. These findings suggest that the
gain-of-function mutant cryopyrin in patients might prop-
agate an inflammatory response without the normal stim-
ulation caused by pathogens. These findings also show
a parallel with pathogen-induced, NB-LRR-mediated cell
death found in plants. A long history of elegant studies in
plants has shown that cell death is a major mechanism
by which plant R proteins mediate host response to multi-
ple microbial pathogens (Belkhadir et al., 2004). It will be
important to determine if other NBD-LRR proteins also
cause the induction of cell death in myeloid and nonmye-
loid cells, and if these proteinsmediate both apoptotic and
necrotic death in a pathogen-specific fashion.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
THP-1 cells were purchased from American Type Culture Collection
(ATCC) and cultured as described previously (Williams et al., 2005).
Anti-caspase-3 antibody was purchased from Cell Signaling; anti-
PARP, anti-ipaB, anti-Actin, and HRP-conjugated secondary anti-
bodies from Santa Cruz Biotechnology; anti-HMGB1 antibody from
Abcam; anti-ASC antibody from Immuno Diagnostic Oy; anti-Cryo-
pyrin antibody from Alexis Biochemicals; Super Signal ECL reagent
from Bio-Rad; E. coli LPS from Chemicon. Detailed methods for prep-
aration of retroviral shuttle vectors, transduction, and sorting to gener-
ate THP-1 cell lines stably expressing shRNA have been described
(Taxman et al., 2006). The shRNA target sequences are as follows:
shASC-GCTCTTCAGTTTCACACCA, shCtrl-GCTCTTCctggcCACAC
CA, shCIAS-GGATGAACCTGTTCCAAAA. Stable expression of
shRNA did not induce interferon response as assessed by OAS1
expression (data not shown).
Generation of Recombinant Adenoviruses
Recombinant adenovirus expressing CIAS1 or LacZ was generated
using Adeno-X Expression System (Clontech). Briefly, genes were
subcloned into pShuttle2 intermediate vector and ligated into themod-
ified type 5 human adenoviral genome vector Adeno-X following exci-
sion with PI-Sce and I-Ceu enzymes. Recombinant adenovirus was
then amplified in HEK293 cells and purified using Adeno-X Virus Puri-
fication Kit (Clontech). Viral titers were determined by UNC Viral Vector
Core Facility (UNC-Chapel Hill).
Adenovirus Transduction of THP-1 Cells
THP-1 cells were aliquoted into Falcon 2059 polypropylene tubes at
a density of 106/ml in RPMI 1640 containing 10% FBS. After addition
of adenovirus (moi = 1 unless otherwise noted), cells were centrifuged
at 2000 3 g for 2 hr at 37C. Immediately after centrifugation, cells
were resuspended and incubated at 5 3 105/ml following the addition
of fresh RPMI 1640 containing 10% FBS.
XTT Assay
Cells were plated into 96-well plates at 20,000 cells per well 24 hr after
adenovirus transduction. Fifty microliters of serum-freemedia contain-
ing 25 mM phenazine methosulfate and 1 mg/ml XTT was added to
each well. Plates were read at 450 nM after 4 hr of incubation.
Mitochondrial Membrane Potential Staining
Cells were stained with tetramethylrhodamine ethyl ester, perchlorate
(TMRE) for 25 min at 37C at a final concentration of 5 nM. After stain-
ing, cells were rinsed in PBS, resuspended in 0.5ml PBS, and analyzed
using a FACScan (Becton Dickinson) in FL2.lsevier Inc.
Cell Host & Microbe
Programmed Necrosis Caused by Cryopyrin and ASCImmunoblotting
Immunoblots were performed as described previously (Williams et al.,
2005). Cryopyrin was immunoprecipitated with rabbit anti-CIAS-1
peptide IgG. Expression was confirmed by probing immunoblots
with anti-CIAS1. HMGB1 blots were performed directly on culture
supernatants and developed as indicated.
Quantitative PCR
Total RNA was isolated, cDNA was reversed transcribed, and quanti-
tative PCR was performed using Absolute SYBR green mix (ABgene,
UK) to assess ASC mRNA expression as described (Taxman et al.,
2006). Real-time values were standardized to the expression of 18 s
rRNA and normalized to 100 in control (untransduced) cells. Primers
used for real-time PCR are as follows: ASC-[AACCCAAGCAAGA
TGCGGAAG, TTAGGGCCTGGAGGAGCAAG], 18 s-[CGGCTACCAC
ATCCAAGG, GCTGCTGGCACCAGACTT].
Viaprobe and 7-AAD Cell Staining
Cells were collected and rinsed twice in cold PBS. Pellets were resus-
pended in 0.5 ml PBS with 3 ml Viaprobe (Becton Dickinson) or 1 ml
7-AAD (BD PharMingen). Cells were incubated in the dark for 15 min
before analysis on a FACScan (BD).
Propidium Iodide Staining
Following treatment, cells were collected and pelleted via centrifuga-
tion. Pelleted cells were fixed in 70% ethanol for a minimum of 2 hr,
rinsed once in PBS, then resuspended in PBS containing 1% Triton,
20 mg/ml propidium iodide (Sigma Chemical Co.), and 200 mg/ml RN-
ase A (QIAGEN). The cells were allowed to stain for 15 min or longer
and then analyzed using a FACScan (BD).
ELISA
THP1 samples were harvested 24 hr posttransduction and assayed
with BD OptEIA Human IL-1b ELISA Set (BD Biosciences) and Human
IL-18 ELISA (MBL International). Mouse samples were taken at indi-
cated times postinfection and assayed with BD OptEIA Mouse IL-1b
ELISA Set (BD Biosciences).
Electron Microscopy
THP-1 cells were infected with adenoviruses at moi = 1 and fixed in 2%
paraformaldehyde, 2.5% glutaraldehyde, in 0.15 M sodium phosphate
(pH 7.4) 2 or 6 hr postinfection. Electron microscopy was performed at
the UNC Microscopy Services Laboratory.
Patient Cells
Two female patients (ages 62 and 71) with FCAS were included in the
study. Both FCAS patients had classic clinical presentation and met
diagnostic criteria, as described previously (Hoffman et al., 2001b).
Neither FCAS subject was experiencing significant inflammatory
symptoms at the time of study, nor on regular anti-inflammatory med-
ications. Two female controls (ages 39 and 41) were studied simulta-
neously with the FCAS patients. However, one control was later found
to have significantly abnormal inflammatory responses and therefore
was not included. An additional four male controls aged 27–34 were
subsequently studied. PBMCs were isolated and prepared as previ-
ously described (Stack et al., 2005).
CIAS1 and Caspase-1-Deficient Mice
CIAS1/ and Caspase-1/ mice were described previously and
were respectively produced by Millenium Inc. and Dr. Richard Flavell,
Yale University (Sutterwala et al., 2006). They were backcrossed for
a minimum of six generations to C57BL/6. Macrophages were ob-
tained by peritoneal lavage 5 days after intraperitoneal injection with
4% thioglycollate and cultured in DMEM supplemented with 10% fetal
calf serum and 50 mg/ml penicillin and streptomycin. Bone marrow
macrophageswere harvested from 6- to 8-week-oldmice and cultured
for 7 days in 30% M-CSF conditioned media.Cell Host & MBacterial Infections
Shigella flexneri strain 12022 was obtained from ATCC. 2457T and
BS103 have been described previously (Fernandez-Prada et al.,
1997). THP-1 cells were cultured at 106/ml in antibiotic-free RPMI. All
samples were infected with S. flexneri or S. typhi bacteria at a moi of
50 at 37C for the indicated amount of time. Samples were centrifuged
at 650 3 g for 10 min immediately following addition of bacteria.
Gentamicin (50 mg/ml) was added to cultures 2 hr postinfection.
Supplemental Data
The Supplemental Data include four supplemental figures and can be
found with this article online at http://www.cellhostandmicrobe.com/
cgi/content/full/2/3/147/DC1/.
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